Masahiko Tosaka Selected Research

Masahiko Tosaka Research Topics

Disease

10	Neoplasms (Cancer) 11/2022 - 06/2007
5	Pituitary Neoplasms (Pituitary Adenoma) 10/2022 - 06/2007
3	Craniopharyngioma (Craniopharyngiomas) 05/2022 - 11/2019
3	Adenoma (Adenomas) 07/2017 - 06/2007
3	Prolactinoma (Prolactinomas) 01/2011 - 06/2007
2	Glioma (Gliomas) 03/2024 - 12/2017
2	Hematoma 02/2023 - 03/2006
1	Meningioma (Meningiomas) 03/2024
1	Cerebrospinal Fluid Leak 12/2023
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2023
1	Moyamoya Disease (Moya-Moya Disease) 06/2023
1	Traumatic Subarachnoid Hemorrhage 02/2023
1	Respiratory Insufficiency (Respiratory Failure) 02/2023
1	Brain Contusion 02/2023
1	Persistent Vegetative State (Vegetative State) 02/2023
1	Thrombocytopenia (Thrombopenia) 02/2023
1	Hyponatremia 10/2022
1	Glioblastoma (Glioblastoma Multiforme) 08/2022
1	Lymphoma (Lymphomas) 08/2022
1	Aspiration Pneumonia 05/2022
1	Vomiting 05/2022
1	Sepsis (Septicemia) 05/2022
1	Hypopituitarism (Sheehan's Syndrome) 05/2022
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 05/2022
1	Familial cyclic vomiting syndrome 05/2022
1	Hypophysitis 09/2021
1	Brain Injuries (Brain Injury) 10/2020
1	Cerebral Infarction 10/2020
1	Ischemia 10/2020
1	Ovarian Neoplasms (Ovarian Cancer) 10/2020
1	Hyperthyroidism 01/2017
1	Hemorrhage 01/2015
1	Siderosis 01/2015
1	Leukemia 04/2009
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 07/2007
1	Intracranial Vasospasm 07/2007
1	Vascular Malformations 03/2006
1	Chronic Subdural Hematoma 09/2002
1	Headache (Headaches) 09/2002

Drug/Important Bio-Agent (IBA)

3	Growth Hormone (Somatotropin)IBA 07/2023 - 04/2009
3	Messenger RNA (mRNA)IBA 01/2011 - 06/2007
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2009 - 06/2007
2	Octreotide (Sandostatin)FDA LinkGeneric 04/2009 - 06/2007
1	C-Reactive ProteinIBA 12/2023
1	Fibrinogen (Factor I)FDA Link 02/2023
1	Capsules (Microcapsules)IBA 11/2022
1	Tolvaptan FDA Link 10/2022
1	IsotopesIBA 08/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2022
1	SteroidsIBA 09/2021
1	Contrast MediaIBA 09/2021
1	HexokinaseIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2021
1	Protons (Proton)IBA 10/2020
1	Minocycline (Cyclops)FDA LinkGeneric 10/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2017
1	Fluorine-18IBA 12/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2017
1	HemosiderinIBA 01/2015
1	GelatinIBA 11/2013
1	Coloring Agents (Dyes)IBA 01/2013
1	ProlactinIBA 01/2011
1	Histone MethyltransferasesIBA 04/2009
1	Mitogen-Activated Protein KinasesIBA 04/2009
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2009
1	Y 27632IBA 07/2007
1	rho-Associated KinasesIBA 07/2007
1	ProstaglandinsIBA 07/2007
1	12-deoxyphorbol 13-isobutyrateIBA 07/2007
1	CalciumIBA 07/2007
1	Somatostatin Receptors (Somatostatin Receptor)IBA 06/2007
1	somatostatin receptor type 1IBA 06/2007
1	somatostatin receptor 2IBA 06/2007
1	A-factor (Streptomyces)IBA 06/2007
1	Adrenocorticotropic Hormone (ACTH)FDA Link 06/2007
1	NestinIBA 03/2006

Therapy/Procedure

3	Craniotomy 03/2024 - 02/2023
2	Endoscopes 11/2021 - 11/2019
2	Therapeutics 09/2021 - 07/2007
1	Platelet Transfusion (Blood Platelet Transfusions) 02/2023
1	Fluid Therapy (Oral Rehydration Therapy) 05/2022
1	Conservative Treatment 06/2015
1	Endovascular Procedures 11/2013
1	Aftercare (After-Treatment) 09/2002